Tim Shaw crosses a finish line during Nashville ALS Walk

September 23, 2017 / 0 comments

NASHVILLE, Tenn. (WKRN) – Tim Shaw was dynamic to finish a Walk to Defeat ALS eventuality during Lipscomb University Saturday morning. The former Tennessee Titans actor and Titan-for-Life not usually participated in a walk, he finished it. Shaw, who is battling ALS, was dynamic to travel a whole mile. When he crossed a finish line,…

Read more →

Do YOU unequivocally know ALS? An eye-opening story about a disease

September 23, 2017 / 0 comments

So we consider we know about ALS? Think again. HIGHLANDS RANCH – Mike Cimbura was diagnosed with ALS in 2015. Within 10-months of diagnosis he was on a ventilator, a feeding tube and 100% cramped to his wheelchair. A sheer contrariety to his life prior; zealous cyclist, snowboarder, concerned father and father of 3 kids….

Read more →

Stephen Hawking, take heart: Revalesio’s ALS drug gets regulatory boost from FDA

September 22, 2017 / 0 comments

British physicist Stephen Hawking, shown here during a 2016 talk with Larry King, is roughly totally inept due to ALS though still leads an active veteran life (Credit: Ora.TV) Revalesio, a biomedical association headquartered in Tacoma, Wash., says it’s been privileged to advantage from sovereign incentives for a growth of a drug that could assistance…

Read more →

A energetic quarrel opposite ALS

September 21, 2017 / 0 comments

Jake Anders’ Marketing Entrepreneurship category appears some-more like a bureau of a bustling startup than a Lake Oswego High School classroom. The space vibrates with energy, and delight perforates a air. And after Anders finishes his morning announcements, a students straightforwardly get to work on a plan that has dominated this division and will shortly…

Read more →

Husband and wife’s ALS tour documented in new book

September 20, 2017 / 0 comments

Naperville clergyman Chris Benyo done a guarantee to his mother when she was fighting ALS, a scarcely five-year conflict she mislaid in 2016. “One of a final things that Denise requested was that we write a book together,” pronounced Benyo, 52, of North Aurora. “She suspicion maybe a story could assistance someone else; she was…

Read more →

Laugh on Down a Road

September 19, 2017 / 0 comments

Dear readers, this week my Living Well with ALS column will take a somewhat opposite trail down a highway of wellness. Because, in a query of vital a equivalent life, I’ve schooled that amusement is something we all need to incorporate into a days. And one of a best ways I’ve found to learn how not…

Read more →

Doing Good: Arkansas ALS Association

September 19, 2017 / 0 comments

FAYETTEVILLE, Ark. — ALS is a illness that was comparatively underneath a radar until a few years ago, when a Ice Bucket Challenge exploded on to a amicable media scene. While recognition of a illness is gaining belligerent in a open consciousness, a Arkansas Chapter of a ALS Association has been operative for years to…

Read more →

Welcome to My Column, ‘The Mighty Mind’

September 18, 2017 / 0 comments

Welcome to “The Mighty Mind.” When we was diagnosed with ALS during age 28 in 2015, we felt like we had mislaid everything. My body, but warning or reason, had incited on me, and that meant a finish of so much. My training career, and dreams of motherhood and flourishing aged with my father were…

Read more →

After ALS diagnosis, Swierczek creation many of his time

September 17, 2017 / 0 comments

Whenever Christina Lieffring posts new content, you’ll get an email delivered to your inbox with a link. Email notifications are usually sent once a day, and usually if there are new relating items. source ⦿ http://columbustelegram.com/news/local/after-als-diagnosis-swierczek-making-most-of-his-time/article_d40fdbd7-5273-57c1-9785-16119035f469.html

First Trial of Potential ALS Gene Therapy VM202 Shows Treatment’s Safety

September 16, 2017 / 0 comments

The investigational gene therapy VM202, grown by VM BioPharma and dictated for a diagnosis of amyotrophic parallel sclerosis (ALS), has been shown to be protected and well-tolerated in a tiny Phase 1/2 clinical trial, according to information published in a biography Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. While a study, sponsored by Korean biotech association ViroMed and…

Read more →